A Boost for CombiMatrix

The company attributes a 6 percent year-over year-increase in first-quarter revenues largely to demand for its microarray-based prenatal testing services.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.